RMD ResMed Inc.
$218.27
ResMed Inc. (RMD) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Insider signal
In line
Selling ran in line with RMD's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity
0 buyers in the last 30 days
0 buyers in the last 90 days
2 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
5
33 transactions
Purchases
$0
0 shares
Sales
$24.2M
100,692 shares
Net activity
-$24.2M
purchases less sales
How much of that selling was preplanned? 100% planned / 0% discretionary
10b5-1 plan sales
$24.2M
33 transactions · 100,692 shares
Discretionary sales
$0
0 transactions · 0 shares
Largest single sale: $2.3M.
Where they traded
Buy
Sell
Dot area is proportional to transaction value.
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $222.44 | $1.1M | 466,256 −1.1% of holding | |
| FARRELL PETER C | Director | Sell 10b5-1 | 970 | $234.73 | $227.7K | 51,803 −1.8% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $205.69 | $1.0M | 466,256 −1.1% of holding | |
| FARRELL PETER C | Director | Sell 10b5-1 | 8,000 | $225.00 | $1.8M | 52,773 −13.2% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $218.55 | $1.1M | 466,223 −1.1% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $193.96 | $968.1K | 466,256 −1.1% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $207.82 | $1.0M | 466,223 −1.1% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $225.50 | $1.1M | 466,223 −1.1% of holding | |
| FARRELL PETER C | Director | Sell 10b5-1 | 2,000 | $225.00 | $450.0K | 60,773 −3.2% of holding | |
| Sandercock Brett | Chief Financial Officer | Sell 10b5-1 | 1,000 | $224.31 | $224.3K | 83,495 −1.2% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $251.03 | $1.3M | 466,223 −1.1% of holding | |
| FARRELL PETER C | Director | Sell 10b5-1 | 2,000 | $260.22 | $520.4K | 62,773 −3.1% of holding | |
| Sandercock Brett | Chief Financial Officer | Sell 10b5-1 | 1,000 | $254.30 | $254.3K | 84,495 −1.2% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $273.78 | $1.4M | 466,223 −1.1% of holding | |
| FARRELL PETER C | Director | Sell 10b5-1 | 2,000 | $251.31 | $502.6K | 64,773 −3% of holding | |
| Rider Michael J | Global General Counsel | Sell 10b5-1 | 50 | $260.00 | $13.0K | 9,691 −0.5% of holding | |
| Sandercock Brett | Chief Financial Officer | Sell 10b5-1 | 1,000 | $257.03 | $257.0K | 85,495 −1.2% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $248.46 | $1.2M | 466,223 −1.1% of holding | |
| FARRELL PETER C | Director | Sell 10b5-1 | 2,000 | $248.83 | $497.7K | 66,773 −2.9% of holding | |
| Sandercock Brett | Chief Financial Officer | Sell 10b5-1 | 1,000 | $241.75 | $241.8K | 86,495 −1.1% of holding | |
| Rider Michael J | Global General Counsel | Sell 10b5-1 | 50 | $241.75 | $12.1K | 9,741 −0.5% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $251.41 | $1.3M | 466,223 −1.1% of holding | |
| FARRELL PETER C | Director | Sell 10b5-1 | 2,000 | $251.47 | $502.9K | 68,773 −2.8% of holding | |
| Sandercock Brett | Chief Financial Officer | Sell 10b5-1 | 1,000 | $244.16 | $244.2K | 87,495 −1.1% of holding | |
| Rider Michael J | Global General Counsel | Sell 10b5-1 | 50 | $244.16 | $12.2K | 9,791 −0.5% of holding | |
| De Witte Jan | Director | Sell 10b5-1 | 2,055 | $255.00 | $524.0K | 4,261 −32.5% of holding | |
| FARRELL PETER C | Director | Sell 10b5-1 | 2,000 | $252.05 | $504.1K | 66,110 −2.9% of holding | |
| De Witte Jan | Director | Sell 10b5-1 | 487 | $250.25 | $121.9K | 5,319 −8.4% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 8,011 | $249.75 | $2.0M | 467,866 −1.7% of holding | |
| Sandercock Brett | Chief Financial Officer | Sell 10b5-1 | 3,000 | $247.54 | $742.6K | 85,745 −3.4% of holding | |
| Farrell Michael J. | Chief Executive Officer | Sell 10b5-1 | 8,009 | $282.85 | $2.3M | 467,792 −1.7% of holding | |
| Sandercock Brett | Chief Financial Officer | Sell 10b5-1 | 3,000 | $274.36 | $823.1K | 86,745 −3.3% of holding | |
| Rider Michael J | Global General Counsel | Sell 10b5-1 | 100 | $274.36 | $27.4K | 11,327 −0.9% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.